ETFs Are Net Sellers of Johnson & Johnson (JNJ) on Nov. 5
ETFs Are Net Sellers of Johnson & Johnson (JNJ) on Nov. 5 GuruFocus
Covered in this story
Analyst targets on Johnson & Johnson
- Bernstein: $253 → $270 by Oct 2027 · Market Perform via Investing.com
- RBC Capital Markets: $249 → $280 by Oct 2027 · Outperform via GuruFocus
- RBC Capital Markets: $255 → $290 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $JNJ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Johnson & Johnson →Also covered by 3 other outlets
- ETFs Are Net Sellers of Apple (AAPL) on Nov. 5
- ETFs Are Net Sellers of Microsoft (MSFT) on Nov. 5
- ETFs Are Net Sellers of Amazon (AMZN) on Nov. 5
- ETFs Are Net Sellers of Walmart (WMT) on Nov. 5
- ETFs Are Net Sellers of Amgen (AMGN) on Nov. 5
Dalsna Finance is currently tracking 38 stories mentioning Johnson & Johnson, the earliest published 16 Aug 2023.
Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.